108 related articles for article (PubMed ID: 16474387)
21. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681
[TBL] [Abstract][Full Text] [Related]
22. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
23. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
24. Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway.
Ye M; Luo X; Li L; Shi Y; Tan M; Weng X; Li W; Liu J; Cao Y
Cancer Lett; 2007 Dec; 258(2):199-207. PubMed ID: 18029087
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
26. Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells.
Dornetshuber R; Heffeter P; Kamyar MR; Peterbauer T; Berger W; Lemmens-Gruber R
Chem Res Toxicol; 2007 Mar; 20(3):465-73. PubMed ID: 17326668
[TBL] [Abstract][Full Text] [Related]
27. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
28. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
Selvendiran K; Koga H; Ueno T; Yoshida T; Maeyama M; Torimura T; Yano H; Kojiro M; Sata M
Cancer Res; 2006 May; 66(9):4826-34. PubMed ID: 16651438
[TBL] [Abstract][Full Text] [Related]
29. Distinct roles of Shh and Fgf signaling in regulating cell proliferation during zebrafish pectoral fin development.
Prykhozhij SV; Neumann CJ
BMC Dev Biol; 2008 Sep; 8():91. PubMed ID: 18811955
[TBL] [Abstract][Full Text] [Related]
30. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor signaling regulates zebrafish embryonic growth and development by promoting cell survival and cell cycle progression.
Schlueter PJ; Peng G; Westerfield M; Duan C
Cell Death Differ; 2007 Jun; 14(6):1095-105. PubMed ID: 17332774
[TBL] [Abstract][Full Text] [Related]
32. Total synthesis and conformational analysis of apratoxin C.
Masuda Y; Suzuki J; Onda Y; Fujino Y; Yoshida M; Doi T
J Org Chem; 2014 Sep; 79(17):8000-9. PubMed ID: 25093538
[TBL] [Abstract][Full Text] [Related]
33. Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61.
Huang KC; Chen Z; Jiang Y; Akare S; Kolber-Simonds D; Condon K; Agoulnik S; Tendyke K; Shen Y; Wu KM; Mathieu S; Choi HW; Zhu X; Shimizu H; Kotake Y; Gerwick WH; Uenaka T; Woodall-Jappe M; Nomoto K
Mol Cancer Ther; 2016 Jun; 15(6):1208-16. PubMed ID: 27196783
[TBL] [Abstract][Full Text] [Related]
34. Asymmetric total synthesis of apratoxin D.
Robertson BD; Wengryniuk SE; Coltart DM
Org Lett; 2012 Oct; 14(20):5192-5. PubMed ID: 23057680
[TBL] [Abstract][Full Text] [Related]
35. Apratoxin Kills Cells by Direct Blockade of the Sec61 Protein Translocation Channel.
Paatero AO; Kellosalo J; Dunyak BM; Almaliti J; Gestwicki JE; Gerwick WH; Taunton J; Paavilainen VO
Cell Chem Biol; 2016 May; 23(5):561-566. PubMed ID: 27203376
[TBL] [Abstract][Full Text] [Related]
36. Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity.
Chen QY; Liu Y; Cai W; Luesch H
J Med Chem; 2014 Apr; 57(7):3011-29. PubMed ID: 24660812
[TBL] [Abstract][Full Text] [Related]
37. Potent oxazoline analog of apratoxin C: Synthesis, biological evaluation, and conformational analysis.
Yoshida M; Onda Y; Masuda Y; Doi T
Biopolymers; 2016 Nov; 106(4):404-14. PubMed ID: 26584466
[TBL] [Abstract][Full Text] [Related]
38. Total synthesis of apratoxin A.
Doi T; Numajiri Y; Munakata A; Takahashi T
Org Lett; 2006 Feb; 8(3):531-4. PubMed ID: 16435877
[TBL] [Abstract][Full Text] [Related]
39. Total Synthesis and Biological Evaluation of Apratoxin E and Its C30 Epimer: Configurational Reassignment of the Natural Product.
Wu P; Cai W; Chen QY; Xu S; Yin R; Li Y; Zhang W; Luesch H
Org Lett; 2016 Oct; 18(20):5400-5403. PubMed ID: 27723359
[TBL] [Abstract][Full Text] [Related]
40. Correction to "Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors".
Cai W; Chen QY; Dang LH; Luesch H
ACS Med Chem Lett; 2017 Dec; 8(12):1342. PubMed ID: 29266134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
